Document Detail


Does Polyvinyl Alcohol Particle Size Change the Outcome of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia? Results from a Single-center Randomized Prospective Study.
MedLine Citation:
PMID:  23916874     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: To evaluate whether different polyvinyl alcohol (PVA) particle sizes change the outcome of prostatic arterial embolization (PAE) for benign prostatic hyperplasia (BPH).
MATERIALS AND METHODS: A randomized prospective study was undertaken in 80 patients (mean age, 63.9 y; range, 48-81 y) with symptomatic BPH undergoing PAE between May and December 2011. Forty patients underwent PAE with 100-µm (group A) and 200-µm PVA particles (group B). Visual analog scales were used to measure pain, and rates of adverse events were recorded. PAE outcomes were evaluated based on International Prostate Symptom Score (IPSS) and quality-of-life (QoL) questionnaires, prostate volume (PV), prostate-specific antigen (PSA) levels, and peak flow rate measurements at baseline and 6 months.
RESULTS: No differences between groups regarding baseline data, procedural details, or adverse events were noted. Mean pain scores were as follows: during embolization, 3.2 ± 2.97 (group A) versus 2.93 ± 3.28 (group B); after embolization, 0.10 ± 0.50 (group A) versus 0 (group B; P = .20); and the week after PAE, 0.85 ± 1.65 (group A) versus 0.87 ± 1.35 (group B; P = .96). Patients in group B had greater decreases in IPSS (3.64 points; P = .052) and QoL (0.57 points; P = .07). Patients in group A had a greater decrease in PV (8.75 cm(3); P = .13) and PSA level (2.09 ng/mL; P < .001).
CONCLUSIONS: No significant differences were found in pain scores and adverse events between groups. Whereas PSA level and PV showed greater reductions after PAE with 100-µm PVA particles, clinical outcome was better with 200-µm particles.
Authors:
Tiago Bilhim; João Pisco; Luís Campos Pinheiro; Hugo Rio Tinto; Lúcia Fernandes; José A Pereira; Marisa Duarte; António G Oliveira
Related Documents :
24286564 - Minimal clinically important improvement (mcii) and patient-acceptable symptom state (p...
15645324 - Expectant treatment or cholecystectomy after endoscopic retrograde cholangiopancreatogr...
23851514 - A prospective evaluation of haemodynamics, functional status, and quality of life after...
12409114 - Haemosuccus pancreaticus: treatment by arterial embolization.
23656594 - Effect of probiotics containing lactobacillus paracasei sd1 on salivary mutans streptoc...
11819364 - An experimental study in etiologic effect of pancreas divisum on chronic pancreatitis a...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-8-2
Journal Detail:
Title:  Journal of vascular and interventional radiology : JVIR     Volume:  -     ISSN:  1535-7732     ISO Abbreviation:  J Vasc Interv Radiol     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-8-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203369     Medline TA:  J Vasc Interv Radiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 SIR. Published by Elsevier Inc. All rights reserved.
Affiliation:
University Departments of Anatomy (T.B.); Radiology (T.B., H.R.T., L.F., J.A.P.); Department of Interventional Radiology (T.B., J.P., H.R.T., L.F., J.A.P., M.D.), Hospital Saint Louis. Electronic address: tiagobilhim@hotmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Six-Tr Epithelial Antigen of the Prostate-1 Plays a Role for in vivo Tumor Growth via Intercellular ...
Next Document:  A deficient translocation of CD3?, ZAP-70 and Grb2 to lipid raft, as a hallmark of defective adaptiv...